Founded
Address
Domain Associates LLC
12481 High Bluff Drive
Suite 150
San Diego, CA 92130
United States
Phone
Email
Website
Recent investment activity
KANDO id: 31340
Company type
Venture capital firm focused on life sciences companies.Funding rounds
Investment preferences
Investment focus themes
Top investment portfolio themes
pharmaceuticals (1)
Investment activity status
Active investor
Selected investments
Displaying 126 - 143 of 143Company | Profile | Country | Date | Funding | ||
---|---|---|---|---|---|---|
AtheroGenics Inc | N/A | |||||
aTyr Pharma Inc | Series C | |||||
BioNano Genomics Inc | Developer of technologies for analysis of large biological molecules. | N/A | ||||
BiPar Sciences Inc | Biopharmaceutical company developing and commercializing tumor-selective drugs for cancer patients. | Series C | ||||
BiPar Sciences Inc | Biopharmaceutical company developing and commercializing tumor-selective drugs for cancer patients. | Series B | ||||
British Bio-technology Ltd (British Biotech) | N/A | |||||
Celator Pharmaceuticals | Identifies ratios of synergistic drug combinations in vitro, and fixes ratios in liposomal drug carriers for in vivo treatment of various cancers. | Series D | ||||
Celator Pharmaceuticals | Identifies ratios of synergistic drug combinations in vitro, and fixes ratios in liposomal drug carriers for in vivo treatment of various cancers. | Series C | ||||
Celator Pharmaceuticals | Identifies ratios of synergistic drug combinations in vitro, and fixes ratios in liposomal drug carriers for in vivo treatment of various cancers. | N/A | ||||
Chromacode Inc | High-definition PCR technology which enhances the multiplexing capabilities on existing hardware. | Series C Initial investment | ||||
Clovis Oncology Inc | Series A | |||||
GenVault Corp | Venture | |||||
Kona Medical Inc | Developer of non-invasive treatment for hypertension | Series C | ||||
Martek Biosciences Corp | N/A | |||||
Neurogen Corp | N/A | |||||
SkinMedica Inc | Engages developing, acquiring, and commercializing prescription and non-prescription skin care products that improve the appearance of skin. | N/A Initial investment | ||||
Zogenix Inc | A pharmaceutical company, engages in the development and commercialization of products for the treatment of central nervous system disorders and pain. | Series B Follow-on investment | ||||
Zogenix Inc | A pharmaceutical company, engages in the development and commercialization of products for the treatment of central nervous system disorders and pain. | N/A Initial investment |